CONDITION × MEDICINE
Tirzepatide: dual receptors, weight management and sleep apnoea
Tirzepatide is a peptide that acts at GIP and GLP-1 receptors. Its metabolic actions connect diabetes, body weight and selected obesity-related conditions; this does not make it a universal health tonic.
- TirzepatideType 2 diabetes
Acts through incretin pathways to help glucose regulation.
Match the product to the diabetes indication. Reference ↗
- TirzepatideChronic weight management
Reduces appetite and food intake.
Use within a wider medical care plan. Reference ↗
- Tirzepatide / ZepboundOSA with obesity: specific U.S. indication
Weight-related effects can improve this defined sleep-apnoea population.
Not a general replacement for sleep-apnoea assessment or devices. Reference ↗